Sawai Acquires Sumitomo Stake In Generic Joint Venture
This article was originally published in PharmAsia News
Executive SummarySawai Pharmaceutical acquired Sumitomo Shoji's 30 percent stake in Medisa Shinyaku June 18, making the generic drug maker a Sawai wholly owned subsidiary
You may also be interested in...
UK HTA body NICE is looking to the future and rethinking its approach to data and how they inform its guidance.
Slovenia’s Krka has responded to media reports of “irregularities” at its Romanian subsidiary – including allegations of bribing local doctors to prescribe its products – by pledging to form a special investigation team to immediately examine the matter.